Fundraising Fox
/Companies
Sign in

Aspargo Laboratories

Englewood Cliffs, US · Founded 2019 · Delaware corporation

Find your way into Aspargo Laboratories

Each arrow is one introduction. Sign up to fill in the first one.

28 people can intro you to Michael

Ask Joe Guastella to introduce you to Michael Demurjian

You →Joe · together at New York University →Michael

5 people can intro you to Mario

Ask Jamie Chen to introduce you to Mario Guralnik

You →Jamie · together at Dainippon Sumitomo Pharma →Mario

Sign up to find every way you can get introduced to Aspargo Laboratories

  • Your email: who you already know at Aspargo Laboratories, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Aspargo Laboratories team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Aspargo Labs develops and commercializes therapeutic agents, handling drug development and regulatory submissions to agencies including the FDA, EMA, MHRA, PMDA and Swissmedic. Its team draws on the pharmaceutical, biotechnology, and consumer product industries, with operations across Europe (Spain, Germany, UK and Ireland).

BiotechHealthtechMedical Devices

Founders & leadership

Aspargo Laboratories was founded in 2019 by Michael Demurjian.

MDMichael Demurjian
Michael DemurjianFounder and CEO of Aspargo Laboratories Inc.Michael Demurjian founded Aspargo Laboratories, where he serves as CEO and Chairman developing oral spray drug formulations and delivery systems. He previously held COO and CFO roles at Tyme Inc., a publicly-traded pharmaceutical company, and has worked across finance, operations, and regulatory strategy in pharmaceutical and medical device sectors.
SKSteven Kaplan
Steven KaplanChief Medical Officer
MGMario Guralnik
Mario GuralnikChief Regulatory OfficerMario Guralnik is Chief Regulatory Officer at Aspargo Laboratories, where he oversees therapeutic drug development and regulatory submissions. He brings decades of experience in pharmaceutical and biotechnology product development, including roles in pharmacovigilance and regulatory strategy, and has published research and holds multiple patents in drug safety and development.
MR
Michael RiceNamed on SEC filing
FB
Fred BiehlNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$9.7M disclosed across 3 rounds · 2020–2022

▶$290KraisedDec 2022 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RiceDirector
  • Fred BiehlDirector
  • Michael DemurjianExecutive Officer
Offering amount
$15M
Amount sold
$290K
Minimum investment
$40K
Sales commissions
$20.3K
Placement agents
Gene Abrams, Eric Miller
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMar 2022 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RiceDirector
  • Michael DemurjianExecutive Officer, Director, Promoter
  • Fred BiehlDirector
Offering amount
$60M
Amount sold
$1.5M
Minimum investment
$10K
Sales commissions
$91.9K
Placement agents
Newbridge Securities Corporation
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.9MraisedOct 2020 · 290 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael RiceDirector
  • Michael DemurjianExecutive Officer, Director, Promoter
  • Fred BiehlDirector
Offering amount
$8.5M
Amount sold
$7.9M
Minimum investment
$10K
Sales commissions
$16.7K
Placement agents
David Sukoff, Eagles Coast Capital
First sale
Feb 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.

Companies working in the same space as Aspargo Laboratories.

In the news

Aspargo Laboratories, Inc. Announces Filing of Its Investigational New Drug Application for Sildenafil Oral Sprayglobenewswire.com · Aug 2023

Frequently asked questions

What does Aspargo Laboratories do?
Aspargo Labs develops and commercializes therapeutic agents, handling drug development and regulatory submissions to agencies including the FDA, EMA, MHRA, PMDA and Swissmedic. Its team draws on the pharmaceutical, biotechnology, and consumer product industries, with operations across Europe (Spain, Germany, UK and Ireland).
Who founded Aspargo Laboratories?
Aspargo Laboratories was founded by Michael Demurjian in 2019.
How much funding has Aspargo Laboratories raised?
Aspargo Laboratories has disclosed $9.7M raised across 3 rounds.
Where is Aspargo Laboratories headquartered?
Aspargo Laboratories is headquartered in Englewood Cliffs, US.